After roller-coaster week, CRL forces a reckoning on Orphazyme investors — inflated shares plummet
The meme stock party is over for Orphazyme.
After a week of frenzied trading — where its shares skyrocketed, at one point, more than 1000% for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
